Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

Related Keywords

Australia ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,New Zealand ,Matthew Deyoung ,Douglase Onsi ,Hc Wainwright Bioconnect ,Prnewswire Leap Therapeutics Inc ,Securities Exchange ,Beigene Ltd ,Leap Therapeutics Inc ,Nasdaq ,Chief Executive Officer ,Leap Therapeutics ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Leap Therapeutic ,Annual Report ,Quarterly Reports ,Nc ,Health Care Amp Hospitals ,Biotechnology ,Roadcast Feed Annoucement ,Trade Show News ,